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INTRODUCTION
Hallmarks of myoblast differentiation are the assembly of the
sarcomeres, the mechanical-electrical coupling of cells, and in
the case of skeletal muscle, fusion of individual myoblasts into
multinucleated myotubes. Phosphatidylserine (PS) has recently
been identified as a novel factor related to myoblast
differentiation in vivo during embryogenesis (van den Eijnde
et al., 1997a; van den Eijnde et al., 1999), using the Ca2+-
dependent PS binding protein annexin V (Swairjo et al., 1995)
to detect cell surface exposure of PS. The embryo studies
revealed PS exposure at the cell surface of apparently viable
myoblasts in the developing heart and skeletal muscle. This has
led us to the hypothesis that PS can mediate homotypic
recognition between cardiac and skeletal muscle cells in the
process of intercalated disk- and myotube formation,
respectively (van den Eijnde et al., 1997a).
At present, the molecular control of myogenesis has been
studied in most detail in Drosophila, in particular for skeletal
muscle (Dobberstein et al., 1997). In this species the genes
myoblast city, blown fuse, rolling stone and Drac1G12V have
been shown to be essential to myotube formation. These genes
encode proteins that mediate key processes of recognition and
adhesion and formation of a prefusion complex, as well as
plaque, cell alignment and plasma membrane apposition and
plasma membrane breakdown, respectively. Molecules that
have been implicated in mammalian skeletal muscle
differentiation include active protease nexin, Ca2+, cathespin
B, desmin, GRP49, ERK6, m-calpain, NCAM, N-cadherin,
proteasomes and the H145 antigen (Crescenzi et al., 1994;
Dourdin et al., 1999; Dourdin et al., 1997; Gogos et al., 1996;
Gorza and Vitadello, 2000; Hyodo and Kim, 1994; Lechner et
al., 1996; Li et al., 1994; Moncman and Wang, 1998; Peck and
Walsh, 1993; Seigneurin-Venin et al., 1996). Extending our
knowledge of intercellular interactions in vertebrate muscle
development may aid in the understanding of muscle tissue
repair, which includes the reassembling of intercalated disks in
the infarcted or hibernating heart (Kaprielian et al., 1998;
Matsushita et al., 1999), and the fusion of satellite cells with
damaged myotubes in skeletal muscle after exercise
(Anderson, 1998).
The aim of the present study was to explore in greater detail
the role of cell surface exposure of PS in myoblast
differentiation, both in mouse embryos in vivo, and in
established muscle cell lines C2C12 and H9C2 in vitro.
Because PS exposure is predominantly considered a hallmark
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Cell surface exposure of phosphatidylserine (PS) is shown
to be part of normal physiology of skeletal muscle
development and to mediate myotube formation. A
transient exposure of PS was observed on mouse embryonic
myotubes at E13, at a stage of development when primary
myotubes are formed. The study of this process in cell
cultures of differentiating C2C12 and H9C2 myoblasts also
reveals a transient expression of PS at the cell surface. This
exposure of PS locates mainly at cell-cell contact areas and
takes place at a stage when the structural organization of
the sarcomeric protein titin is initiated, prior to actual
fusion of individual myoblast into multinucleated
myotubes. Myotube formation in vitro can be inhibited by
the PS binding protein annexin V, in contrast to its mutant
M1234, which lacks the ability to bind to PS. Although
apoptotic myoblasts also expose PS, differentiating muscle
cells show neither loss of mitochondrial membrane
potential nor detectable levels of active caspase-3 protein.
Moreover, myotube formation and exposure of PS cannot
be blocked by the caspase inhibitor zVAD(OMe)-fmk. Our
findings indicate that different mechanisms regulate PS
exposure during apoptosis and muscle cell differentiation,
and that surface exposed PS plays a crucial role in the
process of myotube formation.
Key words: Myotube formation, Skeletal muscle development, Heart
development, Apoptosis, Mouse embryo
SUMMARY
Transient expression of phosphatidylserine at cell-cell
contact areas is required for myotube formation
Stefan M. van den Eijnde1,*, Maurice J. B. van den Hoff2, Chris P. M. Reutelingsperger3,
Waander L. van Heerde3, Mieke E. R. Henfling1, Christl Vermeij-Keers4, Bert Schutte1, Marcel Borgers1 and
Frans C. S. Ramaekers1
1Department of Molecular Cell Biology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, PO Box 616, 6200 MD
Maastricht, The Netherlands
2Department of Anatomy & Embryology, Molecular and Experimental Cardiology Group, Academic Medical Center University of Amsterdam,
1105 AZ Amsterdam, The Netherlands
3Department of Biochemistry, CARIM, University of Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands
4Department of Plastic and Reconstructive Surgery, Erasmus University Medical School, PO Box 1738, 3000 DR Rotterdam, The Netherlands
*Author for correspondence (e-mail: vandeneijnde@molcelb.unimaas.nl)
Accepted 5 July 2001
Journal of Cell Science 114, 3631-3642 (2001) © The Company of Biologists Ltd
RESEARCH ARTICLE
3632
of apoptosis, occurring downstream of changes in the
mitochondrion and after caspase activation (Martin et al., 1995;
Verhoven et al., 1999), we compared maturation-induced and
apoptosis-associated PS exposure. To achieve this, the
spatiotemporal pattern of annexin V binding was determined
during myoblast differentiation in relation to a panel of
differentiation and cell death markers. In addition, the function
of surface-exposed PS in myotube formation was studied by
fusion-inhibition studies using annexin V.
MATERIALS AND METHODS
Embryo studies
The procedures for in vivo labeling of PS-exposing cells in mouse
embryos have been described previously (van den Eijnde et al., 1999;
van den Eijnde et al., 1997b). Briefly, vital embryos were collected
from pregnant mice at E10-14 (plug=day 0) without damaging the
extraembryonic membranes. The embryos were injected with 2-3 m l
of annexin V conjugated to biotin (annexin V-biotin B-500; NeXins
BV, Kattendijke, The Netherlands) into the sigmoid vein in the head
and kept alive in annexin V binding buffer (20 mM Hepes (pH 7.4),
132 mM NaCl, 2.5 mM CaCl2, 6 mM KCl, 1 mM MgSO4, 1.2 mM
K2HPO4, 5.5 mM glucose, 0.5% BSA) for 30 minutes at 37°C.
Subsequently, the embryos were fixed with 4% formaldehyde in
binding buffer overnight at 4°C, and stored in 70% ethanol at - 20°C
until further processing for routine paraffin embedding and
sectioning. Sections (5 m m thick) were dewaxed in xylol and hydrated
in a descending alcohol series. Annexin V-biotin binding was detected
by a streptavidin-HRP conjugate (ABC Elite kit, Vector Laboratories,
Burlingame, CA) and an H2O2/3,3¢ -diaminobenzidine
tetraydrochloride (DAB) reaction. Differentiating muscle cells,
including smooth muscle, skeletal muscle and cardiomyocytes were
detected using the anti a -smooth-muscle actin antibody (1:1000,
Clone 1A4, Sigma, Natick, MA, USA). Labeling of a -smooth-muscle
actin was achieved via an H2O2/DAB reaction after 4 hours of
incubation with the primary monoclonal antibody and incubation with
a secondary rabbit-anti-mouse antibody conjugated to HRP.
In vitro studies
Cell lines
Two muscle cell lines were used in this study, both obtained from the
American Type Culture Collection (Manassas, VA): the mouse C2C12
skeletal muscle cell line and the rat H9C2(2-1) cardiomyocyte cell
line (Su et al., 1999). Importantly, the latter cell line has been
described to possess features of skeletal muscle differentiation,
including myotube formation (Menard et al., 1999). This is in contrast
to heart muscle cells in vivo that do not fuse into myotubes but
become connected by intercalated disks. The cells were grown in a
humidified incubator at 5% CO2 and 37°C in growth medium (GM)
consisting of DMEM (ICN Biomedicals BV, Zoetermeer, The
Netherlands) supplemented with 2 mM L-glutamine (Serva,
Heidelberg, Germany), 10% FCS (Gibco, Paisly, UK) and 0.05 mg/ml
gentamycin (AUV, Cuijk, The Netherlands). At 70-80% confluency,
cells were trypsinized (0.125% trypsin (Gibco), 0.02% EDTA and
0.02% glucose in PBS) for 1-3 minutes and split at a 1:5-1:10 ratio.
Myotube formation was induced by replacing GM with differentiation
medium (DM) (Van der Loop et al., 1996). The only difference
between GM and DM is that the latter contains 2% normal horse
serum (Gibco) instead of 10% FCS. To limit autofluorescence, all the
experiments were performed with cells maintained in GM or DM
deficient in neutral red (ICN Biomedicals BV).
As a positive control for myoblast differentiation-dependent
annexin V binding, the BHK-21/C13 cell line (Flow Laboratories,
Irvine, UK) was used, which has been reported to exhibit myoblast
like characteristics, including the formation of multinucleated
myotubes (Van der Loop et al., 1996). As negative controls, the
myeloid cell line U937 (American Type Culture Collection) and the
non-small-cell lung cancer cell line MR65 (Gropp, Philips
Universitäts Klinik, Marburg, Germany) were used.
Reagents
In this study, several variants of human recombinant annexin V were
used: (1) human recombinant annexin V conjugated to Oregon Green
(annexin V-fluo) at a final concentration of 250 ng/ml (annexin V-
Oregon Green, NeXins Research BV); (2) unlabeled recombinant
human annexin V (AnxV; 1-100 m g/ml); (3) its null mutant (M1234;
100 m g/ml), which has mutations in all four Ca2+ binding sites
resulting in a loss of PS binding capacity (Mira et al., 1997); and (4)
M1234 conjugated to Oregon Green (1 m g/ml). 
To test cell viability and apoptosis, the following reagents were
used: propidium iodide (PI, 5 m g/ml; Molecular Probes, Eugene, OR),
CMXRos (Mitotracker® Red, 500 ng/ml; Molecular Probes); Hoechst
33258 (10 m g/ml; Molecular Probes), and zVAD(OMe)-fmk (100 m M,
diluted in DMSO; Alexis Biochemicals, Leiden, The Netherlands).
For immunofluorescence studies, rabbit-derived antibodies were
used against active caspase 3 (polyclonal antibody CM1, 1:40, Idun
Pharmaceuticals Inc., La Jolla, CA), and against annexin V (1:100).
Furthermore, mouse derived mAbs were used directed against the
sarcomeric protein titin (9D10, 1:10; Developmental Studies
Hybridoma Bank). As secondary antibodies, Texas-Red-conjugated
swine anti-rabbit Ig, or rabbit anti-mouse Ig were used as appropriate
(DAKO, A/S, Glostrup, DK). As negative controls, the primary
antibody was omitted; all negative control samples showed an absence
of immunoreactivity. 
Immunocytochemistry
Cells cultured in the presence of annexin V-fluo were rinsed with ice
cold annexin V binding buffer and thereafter fixed with 4%
paraformaldehyde in annexin V binding buffer at 4°C, pH 7.4 for 10
minutes. Then the cells were rinsed twice with PBS, permeabilized
for 10 minutes with 0.005% SDS in PBS at room temperature, rinsed
with PBS containing 1% BSA and incubated at 4°C with CM1
antibody overnight, or one of the other antibodies for 2 hours.
Subsequently, samples were rinsed with the same buffer and incubated
for 2 hours with the appropriate fluorochrome-conjugated secondary
antibody. After incubation with the secondary antibody, the samples
were rinsed again and mounted with glycerol containing DAPI (Sigma
Chemicals, St Louis, MO).
Annexin V binding assays
To test for cell surface exposure of PS, annexin V-fluo was added to
the medium. The cells were maintained in culture for a period ranging
from 15 minutes up to several days in a humidified 5% CO2 incubator
at 37°C. For the longer culture periods, medium including annexin V-
fluo was renewed every 2 days. Cells were studied upon binding of
annexin V-fluo using an inverted fluorescence microscope with
appropriate excitation and emission filters (Zeiss, Oberkochen,
Germany; Leica Microsystems BV, Rijswijk, The Netherlands),
Image acquisition was achieved using Ikaros (2.3) (MetaSystems,
Heidelberg, Germany) or Openlab (Improvision, Lexington, MA)
software. Images and composite figures were prepared using Adobe
PhotoShop (5.0.2) and Illustratator (8.0) software, respectively
(Adobe Systems Inc., San Jose, CA). To some images, deconvolution
software was applied to remove out-of-focus information using the
Openlab package (Improvision).
Myotube fusion-inhibition assay
To test whether recombinant human annexin V could inhibit myotube
formation, C2C12 and H9C2 cells were grown in 96 well plates
(m Clear™ black tissue culture microplates, Greiner Labortechnik,
Frickenhausen, Germany). When the C2C12 cultures had reached
25% or 50% confluency and the H9C2 cultures had reached 95%
JOURNAL OF CELL SCIENCE 114 (20)
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confluency, myoblast differentiation and myotube formation was
induced by replacing GM with DM containing AnxV (1-100 m g/ml)
immediately after the medium switch. Medium with the same amount
of annexin V was refreshed twice a day for the lower doses (1-40
m g/ml) and every third day for the highest dose (100 m g/ml). To
ascertain that annexin V interacted with the myoblasts in a PS-
dependent manner, we used the non-PS-binding annexin V mutant
M1234 at a concentration of 100 m g/ml. As a positive control, cells
were incubated with DM without AnxV or M1234.
On DMd0 and at the end of the culture period (i.e. DMd5 for C2C12
and DMd11 for H9C2), dual interference contrast-microscopy images
were captured of each well. After culturing, cells were fixed in 4%
paraformaldehyde in annexin V binding buffer and stained for the
sarcomeric protein titin as described above. Subsequently, the
complete bottom of the wells with cells attached were cut out with a
scalpel and mounted on a coverslide using glycerol/DAPI. In each
sample, all multinuclear cells were identified by titin staining and their
nuclei were counted on a Zeiss microscope using the 40 · 1.2 NA oil
objective. For each well, the total number of multinucleated cells and
nuclei therein, and the ratio between both were calculated.
Averages±s.e.m. were calculated for the data in each group (control,
M1234 and AnxV), using MS Excel 98 (Microsoft, Redmond, WA).
To test for significance, the Mann-Whitney (non-parametric) test was
applied using SPSS (10.07a) for Macintosh (MacKiev, Cupertino,
CA).
Control experiments
To determine whether fluorescence observed in differentiating H9C2
and C2C12 myoblasts was due to the presence of annexin V-fluo and
not of unconjugated fluorochrome or autofluorescence, annexin V
was immunocytochemically visualized. Using the same
immunocytochemical procedure, it was verified whether unlabeled
human recombinant annexin V had bound to differentiating
myoblasts and the level of endogenous annexin V expression in
C2C12 and H9C2 cells was assessed. Expression of annexin V was
not detected in C2C12 cells, whereas, in apoptotic H9C2 cells, some
endogenous annexin V expression was observed. To quantify the
amount of annexin V in this cell line, an ELISA was performed,
according to the manufacturer’s instructions (Zymutest, Hyphen
Biomed, Andressy, France). Cell lysates were obtained by removing
the medium, adding 100 m l of lysis buffer (10 mM Tris, 1 mM EDTA,
pH 7.4) and collecting the cells with a rubber policeman.
Subsequently, the suspension was subjected to three freeze-thaw
cycles, and stored at - 70°C until simultaneous analysis. The levels
of endogenous annexin V-protein measured in this cell line were,
however, very low, with values ranging from 0.0028-0.0008% per
total protein content.
RESULTS
PS exposure during muscle cell development in
mouse embryos
In areas of skeletal muscle differentiation, labeling with
annexin V was observed in E13 mouse embryos, where most
of the myotubes in the trunk region were positive for cell
surface exposure of PS (Fig. 1). Fig. 1A1-C2 show examples
of annexin V-positive primary myotubes in the cervical,
thoracic and lumbar regions. On the surface of these annexin
V-positive myotubes, annexin V-positive protrusions were
found (Fig. 1D1,D2, open arrowheads). In-between the
Fig. 1. Transient PS exposure by differentiating myoblasts in mouse
embryos. Primary myotubes expose PS transiently at E13 (black
arrows) in the cervical area (boxed area A1,A2), in-between the
developing ribs (boxed area B1,B2) and the lumbar region (boxed
area C1,C2). Frequently, annexin V-positive rounded cells were
found attached to myotubes (D1,D2, arrowheads). Also in these
sections, indications were found that annexin V-positive extensions
arise from these developing myotubes (D1,D2, open arrowheads).
Mitotic cells were negative for annexin V (B2, white arrowhead). At
E14, annexin V staining of myotubes is virtually absent: compare the
labeling for muscle using an anti- a -smooth muscle actin antibody
(E1) with the labeling of surface-exposed PS (E2) in the same
muscle (white arrows) in an adjacent section. For comparison, F
shows annexin V-labeled apoptotic cells in the fusing E11 branchial
arches, both in the mesodermal compartment (arrow) and in the
ectoderm (arrowhead). Bars, 25 m m (C2,D1,D2,F); 40 m m (B2); 200
m m (A2,B1,C1); 500 m m (A1,E1,E2). Abbreviations: b, brain; l,
limb; r, rib.
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myotubes, a mixed population of mononucleate myoblasts, and
fibroblasts, were observed (Ontell and Kozeka, 1984). Many
of these cells were negative for annexin V-biotin, but a
subpopulation of these cells, in particular the more rounded
cells with little cytoplasm were observed to be annexin V-
positive and attached to myotubes (Fig. 1D1,D2, black
arrowheads). The labeled primary myotubes were
characterized by their large diameter, and non-condensed
cytoplasm and nucleus (Ashby et al., 1993b; Stockdale, 1992).
Hence, these cells could be clearly discriminated from
condensed apoptotic cells. Whereas only a few of such
apoptotic cells were found in the developing muscle, many
were observed elsewhere in the embryo at specific sites where
cell death is known to occur (Fig. 1F). Only at these sites was
profound phagocytic activity was observed. At E14, when most
primary myotubes had formed, these a -smooth muscle actin-
positive cells (Fig. 1E1) were mostly negative for annexin V-
biotin (Fig. 1E2).
In summary, our data from developing myotubes indicate
that these viable muscle cells transiently expose PS in a
developmentally regulated manner. No accumulation of
phagocytes was observed in areas of myoblast differentiation.
PS exposure in differentiating myoblast cultures
C2C12 and H9C2 muscle cell lines undergo differentiation
after serum deprivation, as indicated by the process of cellular
elongation, fusion into di- and trinuclear elongated cells and
formation of extremely elongated multinucleated myotubes.
These C2C12 and H9C2 cells were able to bind annexin V-
fluo transiently (Fig. 2). C2C12 muscle cells were found to
bind annexin V within 8 hours after switching from GM to DM
(Fig. 2A1,A2). After 2 days, binding was maximal with
approximately 60% of the cells positive for annexin V. By
contrast, proliferating C2C12 muscle cells (Fig. 2A3) and
myotubes (Fig. 2A4) after 8 days in DM were not labeled with
annexin V-fluo. H9C2 cells behave similarly (Fig. 2B1-4),
except that the first binding of annexin V-fluo was observed
after 2.5 days in DM (Fig. 2B1,B2), was maximal after 8 days
(on average 40% of the cells) and absent again after 12 days.
Mitotic cells (Fig. 2B3) and myotubes (Fig. 2B4) were
negative for annexin V-fluo. In annexin V-positive cells the
distribution pattern of this marker changed time dependently.
Between 15 minutes and 2 hours of incubation the annexin V-
fluo labeling was seen at the cell surface, in-between cells.
After longer incubation periods the annexin V-fluo became
gradually internalized, as could be demonstrated by rinsing
with Ca2+-depleted medium (which dissociates annexin V from
cell surface-exposed PS), resulting in only a partial loss of the
annexin-fluo labeling.
Once negative for annexin V-fluo, cells could not be
relabeled with freshly added annexin V-fluo, even at
quadruple doses (1 m g/ml), indicating that the loss of the
annexin V-fluo signal is not due to depletion of this marker,
and stressing the transient nature of PS exposure. In Fig.
2A2,B2, cells are shown that were incubated with annexin V-
fluo in culture and stained with an anti-human annexin V
antibody after fixation. The co-localization of both markers
indicates that the green annexin V-fluo signal reflects
interaction of intact annexin V conjugates with the myoblasts,
even after prolonged incubation periods. In addition,
analogous experiments showed that unlabeled human
recombinant annexin V, which was used in the fusion
inhibition studies (see below), also specifically bound
differentiating myoblasts since the pattern of immunostaining
of this unlabeled annexin V accurately mirrored the annexin
V-fluo signal.
Since myoblast differentiation is a highly organized process,
we wondered whether the temporal window of annexin V
labeling is related to a particular phase of myoblast
differentiation, as for example indicated by the molecular
organization at the sarcomeric level. To this end, cells were
double-stained for annexin V and titin, which has been shown
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Fig. 2. Double labeling with annexin V-fluo (green) and for DNA
(DAPI, blue) of C2C12 (A) and H9C2 (B) muscle cells shows that
differentiating myoblasts are labeled with annexin V at cell-cell
contact areas (A1,A2,B1,B2, arrows), while mitotic myoblasts
(A3,B3, arrowheads) and multinucleated myotubes (A4,B4,
arrowheads) are negative for annexin V. Immunocytochemistry with
an anti-human annexin V antibody (red) shows co-localization of
these two markers resulting in yellow areas in the overlay (A2,B2).
Bars, 20 m m (A1-3,B1-3); 60 m m (A4,B4).
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to be one of the earliest proteins to become expressed and
organized in the developing sarcomere (van der Ven et al.,
1993). Essentially, the labeling patterns in C2C12 and H9C2
cells were similar (Fig. 3). Double labeling for both markers
was mainly observed at a phase when titin was expressed in
dot-like aggregates (Fig. 3A1,B1). By contrast, virtually all
cells exhibiting a filamentous titin organization were negative
for annexin V-fluo (Fig. 3A2,B2). 
To confirm that the annexin V-fluo interaction with muscle
cells observed in our culture system is a PS-specific event, we
performed negative control experiments using M1234
conjugated to Oregon Green. In none of the experiments with
C2C12 or H9C2 cells was any labeling observed, even after
incubation periods of multiple days or doses up to 1 m g/ml
(data not shown). Double labeling experiments showed that in
differentiating C2C12 and H9C2 cell cultures the annexin V-
fluo-positive cells had a non-disrupted plasma membrane as
concluded from PI exclusion (Fig. 4A2,B2,B3), which
indicates that annexin V stained the cells via an interaction
with PS present at the outer leaflet of the plasma membrane.
Only sporadically, cells were positive for both annexin V-fluo
and PI (Fig. 4A1,B1,B3, arrows), indicating a possible
intracellular annexin V-fluo labeling, which was accompanied
by a postapoptotic/necrotic morphology. Mainly, annexin V-
fluo was observed to label clusters of cells amidst unlabeled
cells (Fig. 4B3). 
Finally, testing annexin V-fluo in cultures of other cell lines
showed that normally only viable differentiating muscle cells
bind annexin V. In line with our hypothesis, differentiating
BHK cells bound annexin V-fluo similar to the C2C12 and
H9C2 muscle cell lines after growth factor deprivation. In
BHK cells, annexin V-fluo was detected at contact areas of
cells with a non-apoptotic morphology as determined with
DAPI staining and dual interference contrast microscopy. By
contrast, U937 and MR65 cultures were only annexin V-
positive when necrotic or apoptotic (data not shown).
Fig. 3. Triple labeling with annexin V-fluo (green), for titin (red) and
DNA (DAPI, blue) of C2C12 (A1,A2) and H9C2 (B1,B2) myoblasts
shows that annexin V labels mainly early differentiating muscle cells
with a punctate titin expression pattern (A1,B1, arrows). At later
stages of differentiation, when the titin-expression pattern becomes
filamentous, myoblasts were almost completely negative for annexin
V-fluo (A2,B2). Bar, 20 m m.
Fig. 4. Differentiating annexin V-binding C2C12 (A1,A2) and H9C2
(B1-3) myoblasts have an intact plasma membrane as detected by PI
exclusion. In all cultures low numbers of solitary annexin V (green)
and PI (red) labeled cells were found (A1,B1,B3, arrows). These
postapoptotic/necrotic cells can clearly be discriminated from
annexin V-positive differentiating myoblasts where annexin V
labeling is preferentially located at cell-cell contact areas (A2, nuclei
stained with DAPI; B2, asterices indicate location of nuclei), and
which are PI impermeable (A2,B2,B3, asterisks indicate location of
nuclei). In-between the cells shown in B2, an annexin V- and PI-
positive cell fragment, most probably resulting from apoptotic cell
membrane blebbing, is present (arrowhead). Bars, 25 m m
(A1,A2,B1,B2); 200 m m (B3).
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Annexin V fusion-inhibition studies
To investigate a possible causal relationship between PS
exposure and myoblast fusion, we analyzed whether annexin
V can inhibit the formation of myotubes in differentiating
C2C12 and H9C2 cells. C2C12 cells grown to 25% or 50%
confluency (Fig. 5A1,A2) and H9C2 cells grown to 95%
confluency (Fig. 5B1,B2) were induced to differentiate by
medium switch. We also induced C2C12 myoblast
differentiation in cells grown to 80-100% confluency.
However, in these cultures the numbers of myotubes that had
formed at DMd5 were too high to permit accurate counting of
myotube numbers and nuclei.
In almost completely confluent cultures, first signs of
‘spontaneous’ myoblast differentiation and myotube formation
were observed before the medium switch (Fig. 5B1,B2,
arrows). In samples cultured in DM without AnxV (Fig.
5A3,B3) and in samples cultured in DM containing M1234
(data not shown), cells became elongated upon medium switch,
aligned and formed giant multinucleated cells. Maximum
myotube formation was observed on DMd5 and DMd11 for
C2C12 and H9C2 cells, respectively. When cultured in DM
containing AnxV, only a few C2C12 myotubes had formed
(Fig. 5A4). H9C2 cultures responded similarly to incubation
with DM with AnxV, although the decrease in myotube
numbers as compared with control incubations was less
extreme (Fig. 5B4). 
For the quantitative and statistical analysis of differences
in myotube formation between myoblasts cultured with or
without AnxV, we counted all myotubes and nuclei therein in
5-17 wells per group. To this end C2C12 cells at DMd5
(Fig. 5A5) and H9C2 cells at DMd11 (Fig. 5B5) were labeled
for titin to identify differentiated multinucleated cells,
and DAPI to count the nuclei. Fig. 6A illustrates the
differences in myotube numbers containing a given number
of nuclei for C2C12 cells that were induced to differentiate
when grown to 50% confluency and H9C2 cells grown to
95% confluency before switching to DM. It is evident from
this figure that for C2C12, AnxV significantly reduces the
number of myotubes compared with control and M1234
incubations, whereas for H9C2 this inhibitory effect is less
pronounced
C2C12 cultures that were induced to differentiate at 25%
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Fig. 5. Recombinant human annexin V (AnxV) inhibits myotube
formation in differentiating C2C12 and H9C2 muscle cell cultures.
C2C12 cells were induced to differentiate in DM when the cultures
were at 25% (not shown) and 50% confluency (A1,A2), and H9C2
cells at 95% confluency (B1,B2). In samples cultured in the
presence of M1234 (not shown) or in the absence of annexin V
(ctrl) myotube formation could clearly be observed in C2C12 cells
at day 5 (DM d5, A3, arrows) and H9C2 cells at day 11 (DM d11,
B3, arrows), and to a lesser extent in cells cultured in DM
containing 100 m g/ml of recombinant human annexin V (A4,B4,
arrows). Note that cells cultured in GM differentiate
spontaneously and form myotubes when reaching 100% confluency
(e.g. B1,B2, arrows). To assess the effect of annexin V on myotube
formation quantitatively, multinucleated cells and their nuclei were
counted in C2C12 cultures at DM d5 (A5) and H9C2 cultures at
DM d11 (B5), after staining of DNA with DAPI (blue), and with
titin (green) to detect differentiating cells. The quantitative results
are shown in Fig. 6 and Table 1. Bar, 100 m m (A1-4,B1-4); 25 m m
(A5,B5).
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confluency (Table 1A), showed no significant differences
between myoblast differentiation in DM or in DM plus
M1234 with respect to myotubes per well, whereas myoblast
differentiation in DM with AnxV resulted in significantly
fewer myotubes compared with control (p=0.001) and M1234
(p=0.014). The average number of nuclei per myotube varied
between 6.3 and 8.1. Inducing differentiation of C2C12 cells
at 50% confluency (Table 1B) resulted in a profound increase
in the number of myotubes formed compared with numbers
in the 25% confluence culture, whereas the average number
of nuclei per myotube was in the same order of magnitude.
Statistically significant differences were observed for the
number of myotubes formed in the presence of AnxV,
compared with myotube formation in the presence of M1234
(p=0.005) or DM only (p=0.002). In H9C2 cells (Table 1C),
a trend was visible for the number of myotubes with highest
values for control cultures, intermediate values for cells
differentiating in medium with M1234, and lowest values for
cells differentiating in medium with AnxV. However,
statistically significant differences were only observed
between control samples and M1234 (p<0.033) and
AnxV (p<0.019) incubated samples. In this cell line the
average number of nuclei per myotube varied between 3.4
and 4.2. 
A dosage-dependent effect of annexin V on myotube
formation is obvious from Fig. 6B, which shows a trend of an
inhibitory effect already at the lowest dose of 1 m g/ml, and a
significant inhibitory effect at a dose of 40 m g/ml (p=0.001)
and above.
Generally these observations strongly indicate that
recombinant human annexin V inhibits myotube formation by
homotypic interaction between muscle cells via surface-
exposed PS.
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Fig. 6. (A) Annexin V inhibits myotube formation in differentiating
C2C12 and H9C2 myoblast cultures via an interaction with PS.
C2C12 and H9C2 cells were induced to differentiate in DM
(control), DM with PS binding-deficient M1234, or DM with 100
m g/ml annexin V (AnxV). The graphs depict myotube distribution as
a function of the number of nuclei they contained on DMd5 in
cultures of C2C12 cells that were induced to differentiate at 50%
confluency, and on DMd11 in cultures of H9C2 cells that were
induced to differentiate at 95% confluency. Data from 6 wells per
group were combined. Statistical analysis of this data is shown in
Table 1. (B) Annexin V inhibits myotube formation dose
dependently. C2C12 cells were induced to differentiate in DM with
indicated concentrations of annexin V and the number of myotubes
were counted in each sample (n=6 per dose). The graph depicts the
average number of myotubes per well as a percentage of control on
DMd5 in myoblast cultures that were induced to differentiate at 50%
confluency. A significant decrease in the number of myotubes formed
was observed at a concentration of 40 m g/ml (**p=0.001) and 100
m g/ml (* p=0.002).
Table 1. Annexin V inhibits myotube formation in
differentiating C2C12 and H9C2 cell cultures
A C2C12 
(25% confluency) Myotubes/well Nuclei/myotube
Control (n=17) 56±5 6.3±0.4
M1234 (n=5) 45±8 8.1±0.4*
AnxV (n=6) 23±4‡,§ 7.1±0.7
B C2C12 
(50% confluency) Myotubes/well Nuclei/myotube
Control (n=6) 141±17 7.1±0.2
M1234 (n=6) 123±14 7.3±0.4
AnxV (n=6) 67±13‡,¶ 7.2±0.2
C H9C2 
(95% confluency) Myotubes/well Nuclei/myotube
Control (n=6) 42±7 4.2±0.2
M1234 (n=6) 27±4* 3.4±0.3‡
AnxV (n=6) 19±4* 3.5±0.2
Myotube formation by differentiating C2C12 and H9C2 cells. Myoblast
differentiation and myotube formation was induced in cultures of C2C12 cells
grown to 25% (A) or 50% (B) confluency, and H9C2 cells grown to 95%
confluency (C) by switching from GM to DM, which contained no annexin V
(control), 100 m g/ml of mutant annexin V (M1234), or 100 m g/ml of annexin
V (AnxV). Number of myotubes and nuclei therein were determined in each
sample at DMd5 and DMd11 in C2C12 and H9C2 cultures, respectively. The
average values±s.e.m. are shown for each group. The Mann-Whitney test
(non-parametric) was applied to determine significance of differences
between control versus M1234 or AnxV (*P<0.05; ‡P<0.005) and between
M1234 versus AnxV (§P<0.05; ¶P≤0.005).
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PS-exposing myoblasts: differentiation or
apoptosis?
PS exposure in apoptotic cells is suggested to be a downstream
effect of mitochondrial changes and activation of the caspase
cascade in the apoptosis signaling pathway. To establish
whether a comparable molecular mechanism underlies PS
exposure in fusing myoblasts, these events were investigated
during in vitro myoblast differentiation (Fig. 7).
Detection of PS exposure with annexin V-fluo, in
combination with CMXRos labeling to indicate the status of
the mitochondrial membrane potential, and DAPI to show
nuclear morphology, demonstrated clear differences between
apoptotic and differentiating C2C12 and H9C2 cells. Apoptotic
myoblasts are stained with annexin V-fluo at the cell’s
circumference, the CMXRos labeling is diffuse, while the
nucleus is pyknotic (Fig. 7A1,B1). By contrast, differentiating
myoblasts have a granular annexin V-fluo distribution pattern,
a granular CMXRos labeling indicating an intact mitochondrial
membrane potential, and uncondensed nuclei (Fig. 7A2,B2).
Activated caspase 3 was present in apoptotic, annexin V-fluo-
positive C2C12 and H9C2 myoblasts (Fig. 7A3,B3,B4,
arrowhead). By contrast, differentiating annexin V-fluo-
positive myoblasts were negative for active caspase (Fig.
7A4,B4, arrow). Further confirmation that annexin V binding
to differentiating myoblasts is unrelated to caspase activity was
obtained from experiments in which C2C12 and H9C2 cells
were cultured in DM supplemented with the cell-permeable,
general caspase inhibitor zVAD(OMe)-fmk. Up to 5 days after
switching to differentiation medium, the cell cultures with
zVAD(OMe)-fmk showed similar numbers of myotubes (Fig.
7A5,B5) and comparable distribution of annexin V-fluo (Fig.
A6,B6) as the cultures without this caspase inhibitor. In these
cases, it is again evident that after extended incubation periods
annexin V is internalized.
DISCUSSION
At present only limited data are available on surface
molecules that regulate signaling between myoblasts during
muscle development. In this study we show that
differentiating myoblasts transiently express PS at an early
phase of myotube formation, a process that seems not to
involve loss of mitochondrial metabolic activity and activation
of the caspase cascade, as observed for PS exposure during
apoptosis. This translocation of PS from the inner to the outer
plasma membrane leaflet is predominantly found at cell-cell
contact areas. The formation of multinucleated myotubes from
individual differentiating myoblasts can specifically be
blocked with PS-binding annexin V, indicating that cell
surface exposure of PS is essential to the execution of this
process.
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Fig. 7. Annexin V-binding by differentiating C2C12 (A) and H9C2
(B) myoblasts does not require loss of mitochondrial inner
membrane potential or caspase activity. Apoptotic myoblast are
positive for annexin V-fluo (green) and show a diffuse labeling for
CMXRos (A1,B1, arrowhead, red) and immunoreactivity for the
anti-active caspase 3 antibody (A3,B3,B4, arrowhead, red). By
contrast, differentiating C2C12 and H9C2 cells bind annexin
V-fluo while having a granular labeling for CMXRos (A2,B2,
arrow) and show no active caspase 3 protein (A4,B4, arrow). In
line with the latter results, culturing cells in DM containing the
caspase inhibitor zVAD-(OMe)-fmk at a dose of 100 m M blocks
neither myotube formation (A5,B5, arrow) nor annexin V-fluo
binding (A6,B6, arrow). These two figures, in which out-of-focus
information has been removed by image restoration using
deconvolution software, further illustrate the intracellular granular
labeling of myoblasts with annexin V-fluo after longer incubation
periods. Bars, 25 m m.
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Muscle cells transiently expose PS during
differentiation
In this study we present data showing that, during
embryogenesis, morphologically viable myoblasts transiently
bind annexin V, and thus express PS at particular stages of
development. These cells were, however, not in contact with
phagocytes, nor were any phagocytes detected in their vicinity,
as would be expected when these cells were apoptotic (Abood
and Jones, 1991; van den Hoff et al., 2000). In the underlying
study, we have focussed on skeletal muscle development. In
this tissue, binding of annexin V appeared to be a synchronous
process that was present at E13 without the accumulation of
pyknotic cells. Annexin V was not observed anymore at E14
or later, when most primary myotubes have formed, and was
preceding the phase of massive death of primary myotubes that
occurs after E15 (Ashby et al., 1993a).
Since, in the organism, cell surface exposure of PS is a
trigger for phagocytic removal of apoptotic cells (Fadok et al.,
1992b; van den Eijnde et al., 1999), one may wonder how PS-
exposing, differentiating myoblasts remain unnoticed by
phagocytes. Macrophages show tissue specificity with respect
to the receptors used for clearance of apoptotic cells. In E13
mouse embryos, shielding of PS specifically on apoptotic
neurons using annexin V was found to inhibit phagocytosis,
whereas apoptotic mesenchymal cells in the limbs were
ingested by phagocytes (van den Eijnde et al., 1999). This
finding corroborates studies by Fadok and co-workers, who
showed that depending on their activation status, macrophages
may recognize apoptotic cells in a PS-dependent or -
independent manner via integrins (Fadok et al., 1992a).
Another mechanism may relate to the observations that
apoptotic cells can attract phagocytes actively by secreting
chemotactic factors (Knies et al., 1998). PS-exposing viable
muscle cells may, by lacking such factors, avoid the attention
of scavenging cells despite the fact that they bear a putative
signal for cell removal (Knies et al., 1998; Wilson et al., 1996).
Similar to the in vivo situation, two populations of annexin
V binding cells could be discriminated in C2C12 and H9C2
cell cultures, that is, apoptotic and differentiating muscle cells.
In contrast to apoptotic cells, differentiating cells showed
intracellular labeling when incubated with annexin V-fluo for
longer time periods. Endocytosis of annexin V-fluo through
pinocytosis can largely be excluded since co-labeling of
annexin V-fluo with DiI (labeling of the membrane of pinocytic
vesicles) showed hardly any overlap (S.M.v.d.E. et al.,
unpublished). The nature of the annexin V-fluo vesicles in
differentiating muscle cells is not yet known. However, based
upon their cellular localization they resemble: (1) the
cytoplasmic vesicles found in the gap junction-like prefusion
complex that forms at an early stage of myotube formation in
Drosophila, directly following the initial phase of cell
recognition and adhesion; and (2) the plasma membrane
vesicles found during the phase of plasma membrane
breakdown, which is believed to effect cytoplasmic continuity
and actual fusion of myoblasts by removing excess plasma
membrane in-between the fusing cells (Doberstein et al., 1997;
Paululat et al., 1999).
In our in vitro experiments, annexin V was found to almost
exclusively label mononucleated cells in contact with other
mononucleated cells or small myotubes containing a few
nuclei. Large, multinucleated myotubes were unlabeled.
Labeling for the sarcomeric protein titin revealed further detail
about the time-point of PS exposure in myoblast
differentiation. Titin is the first sarcomeric protein expressed
in muscle cells (Van der Loop et al., 1996; van der Ven et al.,
1993); in differentiating muscle cells titin organization changes
from diffuse to punctate, thereafter becomes filamentous and
finally incorporates into sarcomeres, where it exhibits the
typically striated staining pattern. Annexin V-positive
myoblasts were largely characterized by a punctate titin
distribution pattern, while subsequent stages of titin patterns
were rarely observed in these labeled cells. In view of previous
immunocytochemical studies of C2C12 and H9C2 cells (Van
der Loop et al., 1996) or in human skeletal muscle cell cultures
and BHK cells (van der Ven and Furst, 1998; van der Ven et
al., 1993), our results indicate that, in particular, early
postmitotic myoblasts expose PS. Thus, these in vitro data
corroborate our in vivo observations that annexin V binding is
mainly restricted to myoblasts in the process of myotube
formation, and that PS is therefore transiently exposed and
internalized before the fusion process is actually completed.
The localization of PS in the inner plasma membrane leaflet in
most cells is maintained by an aminophospholipid translocase
(Diaz and Schroit, 1996; Zwaal and Schroit, 1997). During
apoptosis and platelet activation, PS becomes cell surface
exposed by a simultaneous translocase inhibition and
scramblase activation (Higgins, 1994; Verhoven et al., 1995).
It remains to be resolved, however, whether the same or similar
transporters regulate loss of PS asymmetry of the plasma
membrane in developing myotubes.
PS exposure during myogenesis is not related to the
molecular cascade of apoptosis 
A possible link between the apoptotic pathway and PS
exposure during muscle cell differentiation was investigated
and could be excluded at the level of loss of mitochondrial
inner cell membrane potential, caspase 3 activation and
caspase activity. In contrast to apoptotic H9C2 and C2C12
cells, annexin V-positive differentiating cells showed none of
these molecular characteristics. In addition, we were unable to
inhibit myotube formation and differentiation-dependent PS
exposure with the broad spectrum caspase inhibitor
zVAD(OMe)-fmk, suggesting that caspases are probably not
directly involved in the loss of plasma membrane PS
asymmetry. Nonetheless, we cannot rule out that PS exposure
by myoblasts is triggered by a short and transient loss of
mitochondrial membrane potential (Minamikawa et al., 1999).
We consider it likely that PS exposure during muscle
development is regulated via factors upstream of the
mitochondrion. This hypothesis is substantiated by several
recent studies, indicating that PS exposure does not always
require caspase activity, and that this plasma membrane
alteration can be reversed (Hammill et al., 1999; Williamson
et al., 1995).
Physiological function of PS exposure in myoblast
interactions
Using the merocyanin 540 dye for labeling of loose lipid
packing of plasma membranes, Sessions and Horwitz, as early
as 1981, suggested that in primary cultures of chick and quail
myoblasts PS was exposed at the cell surface when these were
expected to fuse (Sessions and Horwitz, 1981). From these
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results, they hypothesized that an increase in the percentage of
the PS in the outer plasma membrane leaflet may give rise to
an increase in membrane fluidity. In turn, this increased
membrane fluidity could create a biochemical
microenvironment facilitating the fusion process. Data
presented in this study also indicate that cell surface-exposed
PS is required for differentiating muscle cells to fuse into
multinucleated myotubes. A significant decrease was observed
in the numbers of myotubes formed in myoblast cultures
containing 40 and 100 m g/ml of recombinant human annexin
V. Generally, C2C12 cells showed more prominent features of
differentiation than H9C2 cells. This may relate to the fact that
C2C12 cells are of skeletal myoblast origin, whereas H9C2
cells derive from cardiac myoblasts. Cells from this lineage
normally become connected via intercalated disks and do not
form myotubes, neither in vivo nor in primary cultures (Kostin
et al., 1999). It may be expected, therefore, that H9C2 cells are
at least partially deficient in the expression of molecules
regulating myoblast fusion and are less efficient in executing
this process. In all experiments, a limited effect of the annexin
V mutant M1234 on myotube formation was observed, which
was borderline-significant in H9C2 cell cultures. This finding
suggests that this annexin V mutant, which does not bind PS
that is present in artificial bilayers of phosphatidylcholine
(C.P.M.R., unpublished), may have a residual interaction with
PS in biological membranes. Alternatively, it may suggest a
PS-independent interaction of M1234 with myoblasts. At
present, the nature of these interactions remains to be resolved. 
Data from the fusion inhibition experiments indicate that PS
is of physiological importance to myotube formation. A well
documented function of PS is phagocyte recognition of
apoptotic cells (Fadok et al., 2000; Hamon et al., 2000; Schroit
et al., 1985; Verhoven et al., 1995), involving PS exposure at
the plasma membrane of both scavenger and prey (Marguet et
al., 1999). Cell-cell recognition is considered the initial event
in myotube formation (Doberstein et al., 1997; Paululat et al.,
1999), and we therefore consider it likely that PS has an
analogous function in phagocytosis and myotube formation. In
this respect, the phenomenon of partial inhibition of myotube
formation by high doses of annexin V may relate to the timing
of interference with the fusion process, at which a fraction of
the cells may have already completed their recognition phase.
Interestingly, a similar partial inhibitory effect of has been
observed in studies on the role of PS in phagocytic removal of
apoptotic cells. In several phagocyte lineages the decrease in
phagocytic activity also maximized at approximately 50%,
irrespective of the inhibitory agent used (i.e. annexin V at a
dose 18-180 m g/ml (Bennett et al., 1995), PS-containing
liposomes, or antibodies against a putative PS receptor (Fadok
et al., 2000)). This partial inhibition of phagocytosis is
explained by the existence of multiple pathways in which PS
is a membrane component amongst others orchestrating the
engulfment.
A function of PS in homotypic cell-cell interactions would
fit our observations that PS is initially exposed at the plasma
membrane at myoblast cell-cell contact areas by early
differentiating muscle cells. In addition, it could explain our
observation of a transient exposure of PS in the developing
heart in mouse embryos at E12 (Fig. 8). In heart development,
homotypic cell recognition is possibly of importance to the
formation of intercalated disks. PS exposure was detected, in
particular, in sub-epicardial ventricular cardiomyocytes and the
smooth-walled atrial myocardium in a spatiotemporal
distribution, which did not match early descriptions of cell
death foci in the developing heart (van den Hoff et al., 2000).
PS may be implicated in homotypic recognition between
muscle cells by interacting with a receptor. A putative receptor
for PS, which is highly expressed in developing heart and
skeletal muscle, has recently been identified and cloned by
Fadok and co-workers (Fadok et al., 2000). Another candidate
receptor is thrombospondin, which has been reported to bind
PS (Tooney et al., 1998) and to be expressed in mouse
embryonic heart and skeletal muscle (Manodori et al., 2000)
in a pattern that is mirrored by the pattern of in vivo PS
exposure described here. Alternatively, PS exposure can
mediate cell signaling. This may be achieved in a direct manner
to the cytosol via lipid rafts, as has been shown to occur in
differentiating B cells (Dillon et al., 2000). In addition, PS may
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Fig. 8. PS is transiently exposed by differentiating cardiomyocytes of
E12 mouse embryos. Adjacent transverse sections were stained for
a -smooth muscle actin to detect cardiac muscle cells (A) and
annexin V to label surface-exposed PS (B). Boxed areas in A1 and
B1 are depicted at a higher magnification in A2 and B2 (upper box),
and A3 and B3 (lower box). A strong annexin V-biotin labeling was
observed in the smooth-walled atrial myocardium (A2,B2, arrow),
the subepicardial ventricular myocardium (A2,A3,B2,B3, in-between
arrowheads) and the epicardium (A2,A3,B2,B3, open arrowhead).
Also, at this stage of development, some pyknotic cardiomyocytes
were observed in the trabecular myocardium (A3,B3, open arrows).
Bars, 25 m m (A2,B2); 50 m m (A3,B3); 500 m m (A1,B1).
Abbreviations: n, neural tube; l, limb; p, pericardial cavity.
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give rise to cell signaling in an indirect manner via catalyzing
the conversion of prothrombin into thrombin. In myoblasts this
could result in a signal for cell survival after the interaction of
thrombin with its receptor, which is present at the myoblast
surface prior to fusion (Chini et al., 1999; Suidan et al., 1996).
Taken together, our studies in combination with those of
others strongly indicate a physiological role of cell surface
exposure of PS in myoblast differentiation. 
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